Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07868432
NA

Glycemic Impact of NNS Via the Gut Microbiome

Sponsor: Tufts University

View on ClinicalTrials.gov

Summary

This pilot study will evaluate the feasibility and acceptability of a 30-day sucralose intervention among adults with prediabetes. Participants will consume six commercial sucralose (Splenda®) packets daily for 30 days while wearing a blinded continuous glucose monitor (CGM). Oral glucose tolerance tests (OGTTs) with blood draws will be performed at baseline and after 30 days to assess glucose incremental area under the curve (iAUC). Stool samples will also be collected to assess the feasibility of microbiome sample collection for future studies. The study will generate preliminary data to inform the design of a larger randomized clinical trial examining the effects of non-nutritive sweeteners on glucose homeostasis and the gut microbiome.

Official title: Non-Nutritive Sweeteners, Glucose Homeostasis, and the Gut Microbiome in Prediabetes

Key Details

Gender

All

Age Range

35 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-10

Completion Date

2027-07

Last Updated

2026-10-09

Healthy Volunteers

No

Conditions

Interventions

DIETARY_SUPPLEMENT

Sucralose

Sucralose (Splenda®): six commercial tabletop packets daily, totaling 72 mg sucralose per day, for 30 days.

Locations (1)

Tufts Medical Center

Boston, Massachusetts, United States